Abstract 4714: Mechanisms by which the Rac & Cdc42 inhibitor MBQ-167 overcomes the adverse effects of paclitaxel in TNBC

Authors: Nilmary Grafals-Ruiz, Patricia Sánchez-Orive, Anamaris Torres-Sánchez, Ailed Cruz-Collazo, Derealise García-Almedina, Stephanie Dorta-Estremera, Suranganie Dharmawardhane

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-4714

Source: Full article

---

Abstract

Abstract